Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sebetralstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KalVista Presents Sebetralstat Data at Allergy Congress 2024
    KalVista Presents Sebetralstat Data at Allergy Congress 2024

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241028943529/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    KalVista Presents Sebetralstat Data At HAEi Global Forum
    KalVista Presents Sebetralstat Data At HAEi Global Forum

    04 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241004668357/en

    BUSINESSWIRE
    04 Oct 2024
    Share Share
    KalVista To Present Nine Abstracts At HAEi GAF
    KalVista To Present Nine Abstracts At HAEi GAF

    26 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240926623784/en

    BUSINESSWIRE
    26 Sep 2024
    Share Share
    KalVista Pharmaceuticals Presents Sebetralstat Data at Bradykinin Symposium 2024
    KalVista Pharmaceuticals Presents Sebetralstat Data at Bradykinin Symposium 2024

    06 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240906021663/en

    BUSINESSWIRE
    06 Sep 2024
    Share Share
    KalVista Pharmaceuticals Reports Fiscal Q1 Results and Operational Update
    KalVista Pharmaceuticals Reports Fiscal Q1 Results and Operational Update

    05 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240905441557/en

    BUSINESSWIRE
    05 Sep 2024
    Share Share
    KalVista Announces FDA Acceptance of Sebetralstat for Hereditary Angioedema
    KalVista Announces FDA Acceptance of Sebetralstat for Hereditary Angioedema

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903673442/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share